Home > Boards > US Listed > Biotechs > INSMED (INSM)

INSMED OFFERING

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
[SMART MONEY]  Member Profile
Member Level 
Followed By 3,504
Posts 132,600
Boards Moderated 26
Alias Born 08/05/09
160x600 placeholder
Insmed to Host Third Quarter 2020 Financial Results Conference Call on Thursday, October 29, 2020 PR Newswire (US) - 10/20/2020 8:00:00 AM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 10/2/2020 8:00:00 AM
Insmed Highlights Progress Across Portfolio and Outlines Growth Strategy at R&D Day PR Newswire (US) - 9/30/2020 8:00:00 AM
Insmed to Host R&D Day on September 30, 2020 PR Newswire (US) - 9/16/2020 8:00:00 AM
Insmed to Present at Three September Conferences PR Newswire (US) - 9/9/2020 4:05:00 PM
New England Journal of Medicine Publishes Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cyst... PR Newswire (US) - 9/7/2020 11:24:00 AM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 9/4/2020 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/13/2020 4:12:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/12/2020 5:17:35 PM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 8/7/2020 8:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2020 7:31:30 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2020 7:31:02 AM
Insmed Reports Second Quarter 2020 Financial Results and Provides Business Update PR Newswire (US) - 8/6/2020 7:30:00 AM
Insmed to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 6, 2020 PR Newswire (US) - 7/27/2020 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/24/2020 9:38:47 AM
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infect... PR Newswire (US) - 7/24/2020 7:39:00 AM
Insmed Receives Positive CHMP Opinion for ARIKAYCE Liposomal 590 mg Nebuliser Dispersion for the Treatment of NTM Lung Infect... PR Newswire (US) - 7/24/2020 7:36:00 AM
New NTM Treatment Guidelines Recommend Insmed's ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of Patient... PR Newswire (US) - 7/7/2020 8:00:00 AM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 7/6/2020 8:00:00 AM
Positive Results from Phase 2 WILLOW Study of Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis Presented at AT... PR Newswire (US) - 6/24/2020 4:01:00 PM
Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCF... PR Newswire (US) - 6/8/2020 8:00:00 AM
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (US) - 6/5/2020 8:00:00 AM
Insmed to Present at Two June Conferences PR Newswire (US) - 5/26/2020 8:00:00 AM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 5/21/2020 4:10:30 PM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 5/21/2020 4:08:11 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences